The ongoing battle against COVID-19 has led to numerous scientific breakthroughs, with one of the most promising being the inhibition of FasL (Fas ligand) to treat severe cases. This article delves into the impacts of FasL inhibition on the recovery and mortality of severe COVID-19 patients, based
Blockchain technology is revolutionizing various industries, and healthcare is no exception. By providing a decentralized and immutable way to manage data, blockchain is enhancing data security, transparency, and operational efficiency in healthcare. This article explores how blockchain is
The global C-arms market is on the cusp of significant transformation, driven by technological advancements and evolving healthcare needs. Valued at $2.21 billion in 2023, the market is projected to reach $2.35 billion in 2024, continuing its growth trajectory. This article delves into the key
The landscape of Alzheimer’s disease (AD) diagnosis and treatment is undergoing a significant transformation thanks to the groundbreaking Simoa® technology by Quanterix. This ultra-sensitive immunoassay platform is reshaping how biomarkers are identified and validated, offering new possibilities
The quest for faster and more efficient protein structure prediction has taken a significant leap forward with the advent of MassiveFold, a new iteration of AlphaFold designed for parallel processing. Within the realm of molecular biology and drug discovery, the speed and accuracy of protein
A new partnership between two powerhouses in the pharmaceutical industry promises substantial advancements in drug discovery and development. Novartis, one of the largest pharmaceutical companies globally, will pay Schrödinger $150 million upfront to utilize its advanced computing tools and
The field of regenerative medicine has seen remarkable advancements over the past few decades, with stem cell therapies emerging as a promising frontier. These therapies hold the potential to revolutionize the treatment of a wide array of diseases and conditions by harnessing the body's own repair
The University of Texas MD Anderson Cancer Center has unveiled its ambitious new initiative, the Institute for Cell Therapy Discovery & Innovation, fueled by an impressive initial funding of over $80 million. This pioneering institute aims to revolutionize the realms of immunology and cell
The recent approval of Aucatzyl by the FDA marks a significant advancement in the treatment landscape for patients with B-cell precursor acute lymphoblastic leukemia, especially those whose disease has progressed following initial chemotherapy treatments. Developed by U.K.-based Autolus
South Korea's pharmaceutical and biotech industry is witnessing a fascinating shift as Contract Development and Manufacturing Organizations (CDMOs) and biosimilar developers are experiencing robust growth, while traditional pharmaceutical companies lag. At the forefront of this transition is
ITCurated uses cookies to personalize your experience on our website. By continuing to use this site, you agree to our Cookie Policy